Interaction between the HPV E7 oneoprotein and the transcriptional coactivator p300

被引:108
作者
Bernat, A
Avvakumov, N
Mymryk, JS
Banks, L
机构
[1] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
[2] Univ Western Ontario, London Reg Canc Ctr, Dept Microbiol & Immunol, London, ON N6A 4L6, Canada
[3] Univ Western Ontario, London Reg Canc Ctr, Dept Oncol, London, ON N6A 4L6, Canada
[4] Univ Western Ontario, London Reg Canc Ctr, Dept Physiol, London, ON N6A 4L6, Canada
[5] Univ Western Ontario, London Reg Canc Ctr, Dept Pharmacol, London, ON N6A 4L6, Canada
关键词
HPV; E7; p300 transcriptional coactivation;
D O I
10.1038/sj.onc.1206896
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection with high-risk human papillomaviruses (HPV) can lead to the development of cervical cancer. This process depends on the interaction of the virus-encoded oncoproteins, E6 and E7, with a variety of host regulatory proteins. As E7 shares both functional and structural similarities with the Adenovirus E1a (Ad E1a) protein, we were interested in investigating the possible interactions between E7 and the transcriptional coactivator p300, since it was originally identified as a target of Ad E1a. Using a variety of assays, we show that E7s from both high- and low-risk HPV types interact with p300. Mutational analysis of E7 maps the site of the interaction to a region spanning the pRb-binding domain and the CKII phosphorylation site. We also map the site of interaction on p300 largely to the CH1 domain. In addition, we demonstrate that the binding between 16E7 and p300 is direct, and can be detected in vivo by coimmunoprecipitation and mammalian two-hybrid assays. Finally, we show that E7 can abolish the p300-mediated E2 transactivation function, suggesting that complex formation between E7 and p300 may contribute to the regulation of E2 transcriptional activity.
引用
收藏
页码:7871 / 7881
页数:11
相关论文
共 86 条
[1]  
ABRAHAM SE, 1993, ONCOGENE, V8, P1639
[2]   IDENTIFICATION OF THE HPV-16 E6 PROTEIN FROM TRANSFORMED MOUSE CELLS AND HUMAN CERVICAL-CARCINOMA CELL-LINES [J].
ANDROPHY, EJ ;
HUBBERT, NL ;
SCHILLER, JT ;
LOWY, DR .
EMBO JOURNAL, 1987, 6 (04) :989-992
[3]   The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors [J].
Antinore, MJ ;
Birrer, MJ ;
Patel, D ;
Nader, L ;
McCance, DJ .
EMBO JOURNAL, 1996, 15 (08) :1950-1960
[4]   A FAMILY OF TRANSCRIPTIONAL ADAPTER PROTEINS TARGETED BY THE E1A ONCOPROTEIN [J].
ARANY, Z ;
NEWSOME, D ;
OLDREAD, E ;
LIVINGSTON, DM ;
ECKNER, R .
NATURE, 1995, 374 (6517) :81-84
[5]   Interaction of the HPV E7 proteins with the pCAF acetyltransferase [J].
Avvakumov, N ;
Torchia, J ;
Mymryk, JS .
ONCOGENE, 2003, 22 (25) :3833-3841
[6]  
BANKS L, 1990, ONCOGENE, V5, P1383
[7]   IDENTIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-18 E6-POLYPEPTIDE IN CELLS DERIVED FROM HUMAN CERVICAL CARCINOMAS [J].
BANKS, L ;
SPENCE, P ;
ANDROPHY, E ;
HUBBERT, N ;
MATLASHEWSKI, G ;
MURRAY, A ;
CRAWFORD, L .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :1351-1359
[8]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[9]  
BARBOSA MS, 1989, ONCOGENE, V4, P1529
[10]   Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins [J].
Bernat, A ;
Massimi, P ;
Banks, L .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :829-833